Literature DB >> 8639297

Regional metastases in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.

K Moe1, G T Wolf, S G Fisher, W K Hong.   

Abstract

OBJECTIVES: To determine patterns of regional metastases in patients with advanced squamous cell carcinoma of the larynx and the effect of these patterns on regional and distant tumor recurrence and disease-free and overall survival.
METHODS: One hundred fifty-nine patients treated with conventional surgery and radiation in the Veterans Affairs Cooperative Study were studied. Ninety-three of the patients underwent modified or classic radical neck dissection. Median follow-up was 5 years. Patient data collected included age, gender, alcohol consumption, tobacco use, and performance status. Tumor variables evaluated included TNM classification, tumor site, surface area, presence of ulceration and invasion, and histologic growth pattern. Histologically positive regional lymph nodes were examined for level, number, site, and extracapsular spread. Outcome variables included time and location of recurrence, distant metastases, and survival.
RESULTS: Regional metastases were more common in supraglottic than glottic or subglottic tumors (P < .001) and in tumors with larger surface dimensions (P = .004). Cervical metastases were associated with decreased disease-free interval (P < .001) and survival (P = .001) and increased distant metastases (P < .001). Presence of 3 or more positive nodes predicted distant recurrence (P < .001) and decreased survival (P < .001, multivariate analysis). An analysis of lymph node involvement (levels I-V) indicated that level 1 and 5 involvement was a significant prognostic factor. Age, sex, race, and tobacco or alcohol use were not associated with number or extent of regional metastases.
CONCLUSIONS: These findings confirm the prognostic importance of number and level of lymph nodes in advanced laryngeal cancer. The association of distant metastases with number and level of regional nodes indicates a use for these variables in considering adjuvant chemotherapy.

Entities:  

Mesh:

Year:  1996        PMID: 8639297     DOI: 10.1001/archotol.1996.01890180052013

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  11 in total

1.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

2.  (Chemo)radiotherapy after laser microsurgery and selective neck dissection for pN2 head and neck cancer.

Authors:  Hendrik Andreas Wolff; Friedrich Ihler; Nina Zeller; Christian Welz; Klaus Jung; Martin Canis; Wolfgang Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-12       Impact factor: 2.503

3.  MMP-14 can serve as a prognostic marker in patients with supraglottic cancer.

Authors:  Huiyan Zhang; Ming Liu; Yanan Sun; Jianguang Lu
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-13       Impact factor: 2.503

4.  The impact of treatment center on the outcome of patients with laryngeal cancer treated with surgery and radiotherapy.

Authors:  Fadime Can Akman; Nihal Dag; Ozlem Uruk Ataman; Cenk Ecevit; Ahmet Omer Ikiz; Isin Arslan; Sulen Sarioglu; Emel Ada; Munir Kinay
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-05       Impact factor: 2.503

5.  Evolution of elective neck dissection in N0 laryngeal cancer.

Authors:  O Gallo; A Deganello; J Scala; E De Campora
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-12       Impact factor: 2.124

6.  Lymph node ratio is of limited value for the decision-making process in the treatment of patients with laryngeal cancer.

Authors:  Julian Künzel; Konstantinos Mantsopoulos; Georgios Psychogios; Abbas Agaimy; Philipp Grundtner; Michael Koch; Heinrich Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-19       Impact factor: 2.503

7.  Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement.

Authors:  Mustafa Paksoy; Umit Hardal; Cakır Caglar
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-26       Impact factor: 4.553

8.  Metastasis of laryngeal squamous cell carcinoma to bilateral thigh muscles.

Authors:  Zarah Lucas; Akash Mukherjee; Stanley Chia; Irina Veytsman
Journal:  Case Rep Oncol Med       Date:  2014-12-14

9.  The Prognostic Significance of Lymph Node Ratio and Log Odds Ratio in Laryngeal Squamous Cell Carcinoma.

Authors:  Xinrui Zhang; Feng Yu; Zheng Zhao; Junhao Mai; Yibo Zhou; Guojie Tan; Xuekui Liu
Journal:  OTO Open       Date:  2018-09-27

10.  Tumor Volumes and Prognosis in Laryngeal Cancer.

Authors:  Mohamad R Issa; Stuart E Samuels; Emily Bellile; Firas L Shalabi; Avraham Eisbruch; Gregory Wolf
Journal:  Cancers (Basel)       Date:  2015-11-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.